Selenomethionine regulates cyclooxygenase-2 (COX-2) expression through nuclear factor-kappa B (NF-κB) in colon cancer cells

Durga P. Cherukuri, Anne Christine Goulet, Hiroyasu Inoue, Mark A Nelson

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Previously, we showed that selenomethionine (Se-Met) inhibits growth of colon cancer cells via suppressing COX-2 expression at both mRNA and protein level. However, the molecular mechanism by which Se-Met suppresses COX-2 expression remains to be elucidated. To this end, we transiently transfected HCA-7 cells with different COX-2 promoter constructs followed by Se-Met treatment (90 μM) for 12 h. The results suggested the role of nuclear factor-kappa B (NF-κB) in transcriptional regulation of COX-2. We also observed complete inhibition of DNA binding activity of NF-κB in Se-Met (90 μM) treated HCA-7 cells as shown by electrophoretic mobility shift assay (EMSA). Supershift assays with anti-p65 antibody identified p65 subunit in the protein complex. We further demonstrate dose-dependent inhibition of nuclear translocation of NF-κB/p65 in Se-Met treated HCA-7 cells, which could explain the observed reduction in DNA binding of NF-κB/p65. These results suggest that Se-Met regulates COX-2 at transcriptional level by modulating the activity of NF-κB transcription factor.

Original languageEnglish (US)
Pages (from-to)175-180
Number of pages6
JournalCancer Biology and Therapy
Volume4
Issue number2
StatePublished - Feb 2005

Fingerprint

Selenomethionine
NF-kappa B
Cyclooxygenase 2
Colonic Neoplasms
DNA
Protein Subunits
Electrophoretic Mobility Shift Assay
Anti-Idiotypic Antibodies
Transcription Factors
Messenger RNA
Growth

Keywords

  • Colorectal cancer
  • COX-2
  • NF-κB
  • Selenomethionine

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Selenomethionine regulates cyclooxygenase-2 (COX-2) expression through nuclear factor-kappa B (NF-κB) in colon cancer cells. / Cherukuri, Durga P.; Goulet, Anne Christine; Inoue, Hiroyasu; Nelson, Mark A.

In: Cancer Biology and Therapy, Vol. 4, No. 2, 02.2005, p. 175-180.

Research output: Contribution to journalArticle

@article{ae3e777af9c34131a0ac295dc288ced8,
title = "Selenomethionine regulates cyclooxygenase-2 (COX-2) expression through nuclear factor-kappa B (NF-κB) in colon cancer cells",
abstract = "Previously, we showed that selenomethionine (Se-Met) inhibits growth of colon cancer cells via suppressing COX-2 expression at both mRNA and protein level. However, the molecular mechanism by which Se-Met suppresses COX-2 expression remains to be elucidated. To this end, we transiently transfected HCA-7 cells with different COX-2 promoter constructs followed by Se-Met treatment (90 μM) for 12 h. The results suggested the role of nuclear factor-kappa B (NF-κB) in transcriptional regulation of COX-2. We also observed complete inhibition of DNA binding activity of NF-κB in Se-Met (90 μM) treated HCA-7 cells as shown by electrophoretic mobility shift assay (EMSA). Supershift assays with anti-p65 antibody identified p65 subunit in the protein complex. We further demonstrate dose-dependent inhibition of nuclear translocation of NF-κB/p65 in Se-Met treated HCA-7 cells, which could explain the observed reduction in DNA binding of NF-κB/p65. These results suggest that Se-Met regulates COX-2 at transcriptional level by modulating the activity of NF-κB transcription factor.",
keywords = "Colorectal cancer, COX-2, NF-κB, Selenomethionine",
author = "Cherukuri, {Durga P.} and Goulet, {Anne Christine} and Hiroyasu Inoue and Nelson, {Mark A}",
year = "2005",
month = "2",
language = "English (US)",
volume = "4",
pages = "175--180",
journal = "Cancer Biology and Therapy",
issn = "1538-4047",
publisher = "Landes Bioscience",
number = "2",

}

TY - JOUR

T1 - Selenomethionine regulates cyclooxygenase-2 (COX-2) expression through nuclear factor-kappa B (NF-κB) in colon cancer cells

AU - Cherukuri, Durga P.

AU - Goulet, Anne Christine

AU - Inoue, Hiroyasu

AU - Nelson, Mark A

PY - 2005/2

Y1 - 2005/2

N2 - Previously, we showed that selenomethionine (Se-Met) inhibits growth of colon cancer cells via suppressing COX-2 expression at both mRNA and protein level. However, the molecular mechanism by which Se-Met suppresses COX-2 expression remains to be elucidated. To this end, we transiently transfected HCA-7 cells with different COX-2 promoter constructs followed by Se-Met treatment (90 μM) for 12 h. The results suggested the role of nuclear factor-kappa B (NF-κB) in transcriptional regulation of COX-2. We also observed complete inhibition of DNA binding activity of NF-κB in Se-Met (90 μM) treated HCA-7 cells as shown by electrophoretic mobility shift assay (EMSA). Supershift assays with anti-p65 antibody identified p65 subunit in the protein complex. We further demonstrate dose-dependent inhibition of nuclear translocation of NF-κB/p65 in Se-Met treated HCA-7 cells, which could explain the observed reduction in DNA binding of NF-κB/p65. These results suggest that Se-Met regulates COX-2 at transcriptional level by modulating the activity of NF-κB transcription factor.

AB - Previously, we showed that selenomethionine (Se-Met) inhibits growth of colon cancer cells via suppressing COX-2 expression at both mRNA and protein level. However, the molecular mechanism by which Se-Met suppresses COX-2 expression remains to be elucidated. To this end, we transiently transfected HCA-7 cells with different COX-2 promoter constructs followed by Se-Met treatment (90 μM) for 12 h. The results suggested the role of nuclear factor-kappa B (NF-κB) in transcriptional regulation of COX-2. We also observed complete inhibition of DNA binding activity of NF-κB in Se-Met (90 μM) treated HCA-7 cells as shown by electrophoretic mobility shift assay (EMSA). Supershift assays with anti-p65 antibody identified p65 subunit in the protein complex. We further demonstrate dose-dependent inhibition of nuclear translocation of NF-κB/p65 in Se-Met treated HCA-7 cells, which could explain the observed reduction in DNA binding of NF-κB/p65. These results suggest that Se-Met regulates COX-2 at transcriptional level by modulating the activity of NF-κB transcription factor.

KW - Colorectal cancer

KW - COX-2

KW - NF-κB

KW - Selenomethionine

UR - http://www.scopus.com/inward/record.url?scp=25144451787&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=25144451787&partnerID=8YFLogxK

M3 - Article

C2 - 15655349

AN - SCOPUS:25144451787

VL - 4

SP - 175

EP - 180

JO - Cancer Biology and Therapy

JF - Cancer Biology and Therapy

SN - 1538-4047

IS - 2

ER -